» Articles » PMID: 11409933

Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity

Overview
Specialty Toxicology
Date 2001 Jun 21
PMID 11409933
Citations 385
Authors
Affiliations
Soon will be listed here.
Abstract

Cytochrome P450 (P450) enzymes catalyze a variety of reactions and convert chemicals to potentially reactive products as well as make compounds less toxic. Most of the P450 reactions are oxidations. The majority of these can be rationalized in the context of an FeO(3+) intermediate and odd electron abstraction/rebound mechanisms; however, other iron-oxygen complexes are possible and alternate chemistries can be considered. Another issue regarding P450-catalyzed reactions is the delineation of rate-limiting steps in the catalytic cycle and the contribution to reaction selectivity. In addition to the rather classical oxidations, P450s also catalyze less generally discussed reactions including reduction, desaturation, ester cleavage, ring expansion, ring formation, aldehyde scission, dehydration, ipso attack, one-electron oxidation, coupling reactions, rearrangement of fatty acid and prostaglandin hydroperoxides, and phospholipase activity. Most of these reactions are rationalized in the context of high-valent iron-oxygen intermediates and Fe(2+) reductions, but others are not and may involve acid-base catalysis. Some of these transformations are involved in the bioactivation and detoxication of xenobiotic chemicals.

Citing Articles

Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes.

Faramarzi S, Bassan A, Cross K, Yang X, Myatt G, Volpe D Front Pharmacol. 2025; 15:1451164.

PMID: 40012840 PMC: 11860084. DOI: 10.3389/fphar.2024.1451164.


Selective -Hydroxyketone Formation and Subsequent C-C Bond Cleavage by Cytochrome P450 Monooxygenase Enzymes.

Lee J, Coleman T, McLean M, Podgorski M, Hayball E, Stone I ACS Catal. 2025; 14(11):8958-8971.

PMID: 39911918 PMC: 11793330. DOI: 10.1021/acscatal.4c01766.


Tolterodine is a novel candidate for assessing CYP3A4 activity through metabolic volatiles to predict drug responses.

Stock V, Hofer R, Lochmann F, Spanke V, Liedl K, Troppmair J Sci Rep. 2025; 15(1):2462.

PMID: 39828876 PMC: 11743777. DOI: 10.1038/s41598-025-86450-9.


High Fe-Loading Single-Atom Catalyst Boosts ROS Production by Density Effect for Efficient Antibacterial Therapy.

Chen S, Huang F, Mao L, Zhang Z, Lin H, Yan Q Nanomicro Lett. 2024; 17(1):32.

PMID: 39363132 PMC: 11450126. DOI: 10.1007/s40820-024-01522-1.


CYP3A-Mediated Carbon-Carbon Bond Cleavages in Drug Metabolism.

Zhou J, Qin X, Zhou S, MacKenzie K, Li F Biomolecules. 2024; 14(9).

PMID: 39334891 PMC: 11430781. DOI: 10.3390/biom14091125.